Use of High-Risk Human Papiilomavirus DNA Testing to Deal with Atypical Squamous Cells-Can-not Exclude HSIL

卢薇薇,任国平,吕梨
DOI: https://doi.org/10.3969/j.issn.1672-3686.2009.02.006
2009-01-01
Abstract:Objective To explore the distributable use of high-risk human papillomavirus (HPV) DNA testing to deal with atypical squamous cells-can-not excluding HISL. Methods Totally 112 ASC-H patients tested by liquid- based cytology were included in this study. Hybid capture Ⅱ assay was applied in the high-risk HPV DNA detection. The cervical pathologic diagnoses were obtained under colposcopy guided biopsy. The results of high-risk HPV DNA detection and the pathological diagnosis were compared. Results In 112 patients of ASC-H, the detection rate of CIN I or chronic inflammation was 34.82% (39/112);the patients with positive HPV DNA was 16.88% (13/77) and negative was 74.29%(26/35). The detection rate of CIN Ⅱ-Ⅲ or cervical cancer was 65.18%(73/112); the patients with positive HPV DNA was 83.12%(64/77) and negative was 25.71%(9/35). Detection rate of the lesion below the high squamous cell lesion in patients with negative HPV DNA was higher than that in patients with positive HPV DNA. The difference had statistic significance (χ2=34.93, P0.05). Conclusion High-risk HPV-DNA testing is useful in dealing with the ASC-H patients.
What problem does this paper attempt to address?